Hyperactivated STAT3 signaling has been shown to mediate immunosuppression through tumor cell–intrinsic and –extrinsic mechanisms and is associated with poor clinical prognosis for many cancers, including cervical, lung, and head and neck cancers (40–42), in which elevated SERPINB3 expression is also frequently observed. The gene discussed is STAT3; the disease is head and neck cancer.